269 related articles for article (PubMed ID: 17063173)
1. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
[TBL] [Abstract][Full Text] [Related]
2. Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells.
Betz J; Bauwens A; Kunsmann L; Bielaszewska M; Mormann M; Humpf HU; Karch H; Friedrich AW; Müthing J
Biol Chem; 2012 Mar; 393(3):133-47. PubMed ID: 22718629
[TBL] [Abstract][Full Text] [Related]
3. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.
Sandvig K; Ryd M; Garred O; Schweda E; Holm PK; van Deurs B
J Cell Biol; 1994 Jul; 126(1):53-64. PubMed ID: 8027186
[TBL] [Abstract][Full Text] [Related]
4. Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum.
McKenzie J; Johannes L; Taguchi T; Sheff D
FEBS J; 2009 Mar; 276(6):1581-95. PubMed ID: 19220458
[TBL] [Abstract][Full Text] [Related]
5. Intracellular trafficking of Shiga-toxin-B-subunit-functionalized spherulites.
Bouter A; Delord B; Dransart E; Poirier C; Johannes L; van Effenterre D
Biol Cell; 2008 Dec; 100(12):717-25. PubMed ID: 18564063
[TBL] [Abstract][Full Text] [Related]
6. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect.
Smith DC; Sillence DJ; Falguières T; Jarvis RM; Johannes L; Lord JM; Platt FM; Roberts LM
Mol Biol Cell; 2006 Mar; 17(3):1375-87. PubMed ID: 16381816
[TBL] [Abstract][Full Text] [Related]
7. Endocytosis and retrograde transport of Shiga toxin.
Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Uses of Bacterial Subunit Toxins.
Lingwood C
Toxins (Basel); 2021 May; 13(6):. PubMed ID: 34073185
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells.
Torgersen ML; Engedal N; Pedersen AM; Husebye H; Espevik T; Sandvig K
FEMS Immunol Med Microbiol; 2011 Feb; 61(1):63-75. PubMed ID: 21054580
[TBL] [Abstract][Full Text] [Related]
10. Shiga toxin 'goes retro' in human primary kidney cells.
Paton JC; Paton AW
Kidney Int; 2006 Dec; 70(12):2049-51. PubMed ID: 17136129
[TBL] [Abstract][Full Text] [Related]
11. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.
Sandvig K; Garred O; Prydz K; Kozlov JV; Hansen SH; van Deurs B
Nature; 1992 Aug; 358(6386):510-2. PubMed ID: 1641040
[TBL] [Abstract][Full Text] [Related]
12. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit.
Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP
Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119
[TBL] [Abstract][Full Text] [Related]
13. Manganese blocks intracellular trafficking of Shiga toxin and protects against Shiga toxicosis.
Mukhopadhyay S; Linstedt AD
Science; 2012 Jan; 335(6066):332-5. PubMed ID: 22267811
[TBL] [Abstract][Full Text] [Related]
14. Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.
Tarragó-Trani MT; Storrie B
Adv Drug Deliv Rev; 2007 Aug; 59(8):782-97. PubMed ID: 17669543
[TBL] [Abstract][Full Text] [Related]
15. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.
Falguières T; Mallard F; Baron C; Hanau D; Lingwood C; Goud B; Salamero J; Johannes L
Mol Biol Cell; 2001 Aug; 12(8):2453-68. PubMed ID: 11514628
[TBL] [Abstract][Full Text] [Related]
16. The ether lipid precursor hexadecylglycerol protects against Shiga toxins.
Bergan J; Skotland T; Lingelem AB; Simm R; Spilsberg B; Lindbäck T; Sylvänne T; Simolin H; Ekroos K; Sandvig K
Cell Mol Life Sci; 2014 Nov; 71(21):4285-300. PubMed ID: 24740796
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis for up-regulation by inflammatory cytokines of Shiga toxin 1 cytotoxicity and globotriaosylceramide expression.
Stricklett PK; Hughes AK; Ergonul Z; Kohan DE
J Infect Dis; 2002 Oct; 186(7):976-82. PubMed ID: 12232838
[TBL] [Abstract][Full Text] [Related]
18. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.
Raa H; Grimmer S; Schwudke D; Bergan J; Wälchli S; Skotland T; Shevchenko A; Sandvig K
Traffic; 2009 Jul; 10(7):868-82. PubMed ID: 19453975
[TBL] [Abstract][Full Text] [Related]
19. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
Müthing J; Schweppe CH; Karch H; Friedrich AW
Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
[TBL] [Abstract][Full Text] [Related]
20. Induction of apoptosis of human brain microvascular endothelial cells by shiga toxin 1.
Ergonul Z; Hughes AK; Kohan DE
J Infect Dis; 2003 Jan; 187(1):154-8. PubMed ID: 12508161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
